Cristal Therapeutics appoints Dr Werner Cautreels as a new Director and Board Chairman and Andre Verwei as Chief Financial Officer

1 Aug 2019

Maastricht, The Netherlands, 1st August 2019 – Cristal Therapeutics, a Phase 2 clinical stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announces that Dr Werner Cautreels is...

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

4 Jul 2019

Ghent, Belgium, and Dresden, Germany – 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH today announce a drug discovery collaboration on an undisclosed G-protein coupled receptor (GPCR). The collaboration will combine...

Nederlands biotechsucces lokt beleggers en ‘Big Pharma’

1 Nov 2017

Klik hier voor artikel NRC Handelsblad, 1 november 2017

Investeringsfonds casht op biotechsucces (FD)

27 Jun 2017

See PDF attached >

Van Start-up naar miljardenbedrijf (FD)

22 Oct 2016

See PDF attached >

The Year’s Best VC Deal Was for a Company You’ve Never Heard Of (Forbes)

17 Dec 2015

The Year’s Best VC Deal Was for a Company You’ve Never Heard Of (Forbes) Go to article >